Add to Favourites
To login click here
The global multiplex assays market is expected to reach $6.24 billion by 2030, driven by the preference for multiplex assays over singleplex varieties and advancements in companion diagnostics. The protein multiplex assays segment, specifically bead-based assays, is leading the market due to its critical role in diagnostics for various diseases. The consumables product segment is also seeing growth due to continuous advancements in diagnostic kits.